No known drug interactions for the matched ingredients — not a guarantee none exist. Check your meds →
Dietary supplement

Lecithin 1,200 mg Ingredients & Drug Interactions

by Indiana Botanic Gardens

Softgel Capsule Category: Fat/fatty Acid
No known interaction
The interaction bottom line No known interaction

Lecithin 1,200 mg is a dietary supplement by Indiana Botanic Gardens with 2 active ingredients. Its ingredients are commonly taken for liver health, memory and brain support, ulcerative colitis.We don’t currently list a known drug interaction for its mapped ingredients — but that doesn’t guarantee none exist, so always confirm with your pharmacist.

HelloPharmacist Scorecard of Lecithin 1,200 mg by Indiana Botanic Gardens

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Partial disclosure
Ingredient Transparency · database check
Partial

Most active ingredients list an amount, but at least one is hidden in a blend or missing.

Why this rating?
  • The label discloses an exact amount for 3 of its 4 active ingredients.

This softgel has 4 active ingredients. The main ones are phosphatidyl choline and soy lecithin, both forms of lecithin — a fatty compound that supports cell membranes and may play a role in liver and brain function.

The product also contains monounsaturated and polyunsaturated fats. The softgels themselves are made from gelatin and contain non-GMO soybean oil.

Does it work?

Not established
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not established

The graded evidence we hold for these ingredients covers different conditions than the ones this product is marketed for, so there's no established rating for its stated use.

Why this rating?
  • The label markets this product for: Cholesterol support.
  • We looked for evidence on: Hyperlipidemia, Hyperlipoproteinemia, Atherosclerosis, Peripheral arterial disease (PAD), Angina, Dyslipidemia — and 2 related terms.
  • The closest evidence on file: Phosphatidylcholine is rated "Insufficient Reliable Evidence To Rate" for Angina (Natural Medicines).
  • Also on file: Phosphatidylcholine is rated "Insufficient Reliable Evidence To Rate" for Atherosclerosis, Hyperlipidemia, Hyperlipoproteinemia, Peripheral arterial disease (PAD).
  • Also on file: Lecithin is rated "Insufficient Reliable Evidence To Rate" for Hyperlipidemia.

The evidence for what lecithin does is mixed. Phosphatidyl choline shows possibly effective evidence for ulcerative colitis, but the evidence for other uses — including Alzheimer's disease, nonalcoholic fatty liver disease, alcohol-related liver disease, and anxiety — is either insufficient or not there.

Soy lecithin appears likely ineffective for Alzheimer's disease and has insufficient evidence for age-related cognitive decline, hepatic steatosis with parenteral nutrition, anxiety, and bipolar disorder. If you're considering this for a specific condition, talk it over with your doctor or pharmacist.

The evidence, ingredient by ingredient Phosphatidylcholine Lecithin

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 2 of the 2 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 2 of 2.
  • General safety write-ups exist for 2 of 2.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Both ingredients are generally well tolerated when taken by mouth. That said, high doses of phosphatidyl choline (particularly 30 grams a day, and some people feel effects at smaller amounts) can cause digestive upset, bloating, diarrhea, nausea, vomiting, and altered taste.

Soy lecithin most commonly causes abdominal pain, diarrhea, fullness, and nausea. If you have an egg or soy allergy, lecithin can trigger allergic skin reactions.

For pregnancy, choline (the active form) is needed, but how safe supplements beyond food amounts are during pregnancy isn't well studied — check with your doctor. There isn't enough data on supplement use while breastfeeding; talk with your healthcare provider first.

Side effects, ingredient by ingredient Phosphatidylcholine Lecithin

Meds to double-check

No known interactions
Known Interaction Concern · database check
No known interactions

No medication interactions are currently documented for the matched ingredients — that isn't a guarantee none exist.

Why this rating?
  • None of the 2 matched ingredients has a documented medication interaction on file.

No interactions are documented for the ingredients we could check. That said, we hold no interaction data for the monounsaturated fat and polyunsaturated fat in this product, so check your exact medications using the search tool on this page before you start, just to be thorough.

The bottom line

Scorecard at a glancePartially disclosed formula with no established evidence rating for its marketed use. No medication interactions are currently documented, and safety information is well characterized.

Lecithin may be worth considering if you're looking at phosphatidyl choline specifically for ulcerative colitis support, though the evidence is modest. If you're hoping it'll help with memory or brain health, the evidence doesn't back that up.

Be aware that higher doses can cause digestive symptoms. Chat with your doctor or pharmacist before starting, especially if you're pregnant, breastfeeding, or have a soy or egg allergy.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 2 of 4 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Dec 22, 2017.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Lecithin 1,200 mg, straight from the product label.

Brand Indiana Botanic Gardens
Barcode (UPC) 703308940213
Net contents 90 Softgel(s)
Market status On market
Date entered into DSLD Dec 22, 2017
DSLD ID 77336
Product type Fat/fatty Acid
Supplement form Softgel Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Lecithin 1,200 mg by Indiana Botanic Gardens, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
3 Softgel(s)
Maximum serving Sizes:
3 Softgel(s)
Servings per container
30
UPC/BARCODE
703308940213
IngredientAmount% DV
Calories30 Calorie(s)--
Calories from Fat25 Calorie(s)--
Total Fat2.5 Gram(s)4%
Monounsaturated Fat0 Gram(s)--
Phosphatidyl Choline540 mg--
Trans Fat0 Gram(s)--
Saturated Fat1 Gram(s)5%
Soy Lecithin3.6 Gram(s)--
Polyunsaturated Fat2 Gram(s)--

Other ingredients: Gelatin Capsule, non-GMO Soybean Oil

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

Cholesterol support

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Suggested Use: Take three softgels daily, with meals, as a dietary supplement, or as directed by a physician.

Precautions

Warning: If you are taking any medications or are pregnant or nursing do not use prior to consulting a physician.

For your protection, this container has an outer safety seal. (Do not accept if missing or broken.)

Keep out of reach of children

FDA Disclaimer Statement

This statement has not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Storage

Store at room temperature.

Brand IP Statement(s)

IBG Indiana Botanic Gardens

See for yourself

Lecithin 1,200 mg by Indiana Botanic Gardens label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in Lecithin 1,200 mg by Indiana Botanic Gardens

These are the 2 active ingredients this product is made of. Select any to open its full monograph.

Serving size3 Softgel(s) Dosage formSoftgel Capsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Phosphatidyl Choline

No known
interactions
540 mg per serving

Phosphatidylcholine is a phospholipid that is part of every cell membrane and a source of choline. People take it for liver, brain, and gut health, bu...

Phosphatidyl Choline monograph & interactions

Soy Lecithin

No known
interactions
3.6 Gram(s) per serving

Lecithin is a natural fatty substance found in foods and made by the body that is widely used as a supplement and food emulsifier. Evidence supporting...

Soy Lecithin monograph & interactions

Other (inactive) ingredients: Gelatin Capsule, Non-GMO Soybean Oil. These complete the product’s ingredient list but are not active constituents.

Interaction report

Lecithin 1,200 mg by Indiana Botanic Gardens Drug Interactions

We don’t currently list any known drug interactions for the mapped ingredients in Lecithin 1,200 mg. This doesn’t guarantee none exist — always confirm with your pharmacist before combining a supplement with your medications.

The maker

Brand information

Manufacturer and brand details for Lecithin 1,200 mg, from the product label.

Indiana Botanic Gardens

See all Indiana Botanic Gardens products
Name
Indiana Botanic Gardens, Inc.
Street Address
3401 W. 37th Ave.
City
Hobart
State
IN
ZipCode
46342
Phone Number
1-800-644-8327
Web Address
www.botanicchoice.com
Pharmacist Counseling Corner

Lecithin 1,200 mg by Indiana Botanic Gardens: Common Questions

Does Lecithin 1,200 mg by Indiana Botanic Gardens interact with any medications?
We do not currently list a known interaction for the mapped ingredients in Lecithin 1,200 mg. This does not guarantee none exist, so confirm with your pharmacist.
How can one product interact with so many drugs?
Lecithin 1,200 mg contains 2 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is lecithin, and what does it do in the body?
Lecithin is a fatty compound found in cell membranes that helps with their structure and function. It may support liver and brain health, though the evidence for specific uses varies — some conditions show modest support, and others don't have reliable evidence yet.
Can I take this if I'm pregnant or breastfeeding?
Choline (the active form in lecithin) is needed during pregnancy, but how safe supplements are beyond what you get from food hasn't been well studied. For breastfeeding, there isn't enough data. Talk with your doctor or healthcare provider before taking this supplement if you're pregnant or nursing.
What side effects might I notice?
Most people tolerate it fine, but higher doses can cause bloating, diarrhea, nausea, vomiting, and altered taste. Soy lecithin may also cause abdominal pain, fullness, and nausea. If you have a soy or egg allergy, it can trigger allergic skin reactions.
Will this help with memory or Alzheimer's disease?
The evidence doesn't support it for those uses. Soy lecithin is likely ineffective for Alzheimer's disease, and there isn't reliable evidence for age-related memory decline.
Is this product soy-free?
No — the inactive ingredients include non-GMO soybean oil, and soy lecithin is one of the active ingredients. If you're allergic to soy, this product isn't for you.
What does the phosphatidyl choline ingredient do?
Phosphatidyl choline is a form of choline that may help with ulcerative colitis (the evidence is modest), but for other conditions like Alzheimer's disease, fatty liver disease, and anxiety, the evidence is either insufficient or not there.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Lecithin 1,200 mg is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Lecithin 1,200 mg label
Sources

Sources & How We Checked

Lecithin 1,200 mg's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 24 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Phosphatidylcholine 15 references
  1. Domino EF, May WW, Demetriou S, et al. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy. Biol Psychiatry 1985;20:1189-96. PubMed
  2. Aronson PJ, Lorincz AL. Promotion of palmar sweating with oral phosphatidylcholine. Acta Derm Venereol 1985;65:19-24. DOI
  3. Hexsel DM, Serra M, de Oliveira Dal'Forno T, et al. Cosmetic uses of injectable phosphatidylcholine on the face. Otolaryngol Clin North Am 2005;38:1119-29. PubMed
  4. Kopera D, Binder B, Toplak H, et al. Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case. Am J Dermatopathol 2006;28:331-3. PubMed
  5. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001;27:391-2. PubMed
  6. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006;32:465-80. PubMed
  7. Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003;2:511-8.
  8. Hasengschwandtner F. Phosphatidylcholine treatment to induce lipolysis. Cosmet Dermatol 2005;4:308-13. PubMed
  9. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg 2003;27:315-8. PubMed
  10. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 2004;30:422-7. PubMed
  11. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52(9):1658-65. PubMed
  12. Panos, J. M., Palson, R., Johnson, R., Portmann, B., and Williams, R. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis: a double blind randomized placebo controlled trial. Eur.J.Gastroenterol 1990;2:351-355.
  13. Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101-7. PubMed
  14. Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med. 2007;147(9):603-10. PubMed
  15. Stremmel W, Vural H, Evliyaoglu O, Weiskirchen R. Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis. Dig Dis 2021;39(5):508-515. PubMed

See these in context on the Phosphatidylcholine monograph →

Lecithin 9 references
  1. Buchman AL, Dubin M, Jenden D, et al. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 1992;102:1363-70.
  2. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline (2000). Washington, DC: National Academy Press, 2000. Available at: http://b
  3. Chatellier G, Lacomblez L. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine. BMJ 1990;300:495-9.
  4. Gelenberg AJ, Dorer DJ, Wojcik JD, et al. A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry 1990;51:149-53.
  5. Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:736-42. PubMed
  6. Palm M, Moneret-Vautrin DA, Kanny G, et al. Food allergy to egg and soy lecithins. Allergy 1999;54:1116-7. PubMed
  7. Drachman DA, Glosser G, Fleming P, et al. Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 1982;32:944-50. PubMed
  8. Gelenberg, A. J., Doller-Wojcik, J. C., and Growdon, J. H. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 1979;136(6):772-776. PubMed
  9. Electronic Code of Federal Regulations. Title 21, Chapter 1, Subchapter B, Part 184: Direct food substances affirmed as Generally Recognized as Safe. Subpart B - listing of specific substances affirmed as GRAS. Sec. 184.1400 Lecithin. Available at: https:

See these in context on the Lecithin monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring